Gorostiza will be bringing experience of corporate finance, strategic planning, business transformation and corporate development to the Linneo Health team.
Medical cannabis research and cultivation company Linneo Health has welcomed Gorostiza as Chief Financial and Strategy Officer.
The company has stated that Gorostiza possesses a track record of success leading the financial and strategy functions of a number of multinational businesses, both private and publicly listed.
Read more: Linneo Health explores trends in medical cannabis
Linneo Health CEO, Don Bellamy, commented: “We are delighted to welcome Gerardo to Linneo Health as chief financial and strategy officer.
“He brings a wealth of experience and knowledge, and his strategic mindset and leadership skills will be invaluable to Linneo as we continue to build on our success and growth as the leading provider of medicinal cannabis, for the benefit of patients.”
Gorostiza’s previous roles include Uralita, Adveo and Grupo Costa Food, as well as having worked as a consultant with PricewaterhouseCoopers.
Read more: GMP certification allows Linneo Health to continue cannabis research
Most recently, Gorostiza was CFO and subsequently CEO of Juan Luna, a leading Spanish food processing company, where he played an integral role in the professionalisation of the company and its subsequent sale to a top industrial player.
Gorostiza holds an Executive MBA from the IE Business School in Madrid, Spain, and qualified as an Industrial Engineer with the Universidad del País Vasco, Spain.
Gorostiza commented: “Linneo Health’s fully integrated platform, enabling the research, manufacture and supply of the highest quality medicinal cannabis, puts the company in a prime position to grow at scale as this market matures.
“I am looking forward to working with Don and the team to maintain Linneo’s leading position and continue its expansion.”
[activecampaign form=31]
